{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-377362","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2026-09-01T10:00:27+00:00","discovered_at":"2026-09-01T10:10:11.145524+00:00","generated_at":"2026-09-01T10:10:44.359163+00:00","sec_items":["1.01","2.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Revolution Medicines signs 4-building lease for new Redwood City HQ (672k sq ft, ~$2.7M/mo)","bullets":["Leases for four Seaport Blvd buildings (1600-1900) totaling ~672,000 rentable sq ft as new HQ; effective subject to Phase II Closing.","Commencement staggered Sep 26, 2027–Sep 1, 2028; initial terms end Sep 2042 with three 5-yr extension options.","Aggregate base rent starts ~$2.7M/month at full commencement, +3% annually; rent abatement ~$23.1M through Jan 2030.","Tenant improvement allowances ~$115.9M plus optional additional ~$40.3M (amortized at 10% annually as extra rent).","Related-party: Farallon (owns ~6.4% of RVMD) indirectly owns majority of landlords; Leases create direct financial obligation."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-377362","json":"https://secwatch.observer/filing/0001193125-26-377362.json","markdown":"https://secwatch.observer/filing/0001193125-26-377362.md","text":"https://secwatch.observer/filing/0001193125-26-377362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/0001193125-26-377362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/rvmd-20260827.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T10:10:44.359163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}